Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > AstraZeneca to delist from Nasdaq, join NYSE in February
    Finance
    AstraZeneca to delist from Nasdaq, join NYSE in February

    Published by Global Banking and Finance Review

    Posted on January 20, 2026

    1 min read

    Last updated: January 20, 2026

    AstraZeneca to delist from Nasdaq, join NYSE in February - Finance news and analysis from Global Banking & Finance Review
    Tags:equitytrading platformfinancial communityLondon Stock Exchangedebt instruments

    Quick Summary

    AstraZeneca will delist from Nasdaq and list on NYSE by February 2026, simplifying its share structure and maintaining its 'AZN' ticker.

    Table of Contents

    • AstraZeneca's Listing Transition
    • Details of the Direct Listing
    • Impact on Shareholders

    AstraZeneca to delist from Nasdaq, join NYSE in February

    AstraZeneca's Listing Transition

    Jan 20 (Reuters) - AstraZeneca  on Tuesday said it would delist its American Depositary Shares and debt securities from Nasdaq and complete a direct listing of its ordinary shares and debt on the New York Stock Exchange, effective after market close on January 30, 2026.

    Details of the Direct Listing

    The ordinary shares and debt securities are expected to commence trading on the NYSE from February 2, with AstraZeneca maintaining its "AZN" ticker symbol.

    Impact on Shareholders

    The move is part of a shareholder-approved plan to unify the company's share listing structure, allowing investors to trade its ordinary shares across the London Stock Exchange, Nasdaq Stockholm and the NYSE.

    Following implementation of the harmonised structure, AstraZeneca will shift from trading ADSs - which represent ordinary shares on a two-for-one basis - to a direct listing of its $0.25 ordinary shares, simplifying its multi-market trading setup.

    (Reporting by Yamini Kalia in Bengaluru)

    Key Takeaways

    • •AstraZeneca will delist from Nasdaq and list on NYSE.
    • •Transition to occur after market close on January 30, 2026.
    • •Trading on NYSE begins February 2, maintaining 'AZN' ticker.
    • •Move simplifies AstraZeneca's multi-market trading setup.
    • •Shareholders approved the unified share listing structure.

    Frequently Asked Questions about AstraZeneca to delist from Nasdaq, join NYSE in February

    1What is a direct listing?

    A direct listing is a method for a company to go public by allowing existing shareholders to sell their shares directly on an exchange without the need for an underwriter.

    2What are American Depositary Shares (ADS)?

    American Depositary Shares (ADS) are a way for U.S. investors to buy shares in foreign companies, representing a specific number of the company's shares.

    3What is the NYSE?

    The New York Stock Exchange (NYSE) is one of the largest stock exchanges in the world, where shares of publicly traded companies are bought and sold.

    4What is a ticker symbol?

    A ticker symbol is a unique series of letters assigned to a security or stock for trading purposes, used to identify the company on the stock exchange.

    5What is the London Stock Exchange?

    The London Stock Exchange (LSE) is a stock exchange located in London, where shares of publicly traded companies are listed and traded.

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Previous Finance PostTotal flags stronger refining margins, lower oil and gas sales in trading update
    Next Finance PostGSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy
    More from Finance

    Explore more articles in the Finance category

    Shell's projects and technology president Robin Mooldijk to step down
    Moscow says it expects U.S. to release Russian crew from seized Venezuela-linked tanker
    Deal to sell stake in Serbia's NIS to Hungary's MOL would benefit Russia, Lavrov says
    UK's development finance agency anchors $1 billion blended finance fund for emerging markets
    Shipping group CMA CGM scales back Suez sailings on geopolitical risks
    M&S tech chief departs less than a year after costly cyberattack, Sky News reports
    US Treasury Secretary Bessent brushes off 'hysteria' over Greenland
    Lamborghini flags record deliveries at 10,747 cars in 2025 worldwide
    QinetiQ to align US business with Trump's defense priorities
    Imperial Brands names John Rishton as new chair
    Czech billionaire's CSG launches record defence IPO, aiming to raise 3.8 billion euros
    Total flags stronger refining margins, lower oil and gas sales in trading update
    View All Finance Posts